Find and Pitch Jounalists, Get Your Story Covered

Tags: MDMA ecstasy PTSD therapy denver denver botanic garden

	Profile	Recent Articles on Subject
1	Nicoletta Lanese Live Science Science journalist. New York, USA sciencehealthjournalism	When will MDMA be approved for therapy? Major trial issues may stand in the way, psychiatrist Dr. Albino Oliveira-Maia says. - about 1 month ago
2	John Pinching PharmaTimes Next-gen biopharma company. La Jolla, California biopharmadrugsdevices	Beckley Psytech announces positive results for ELE-101 in depression trial - about 1 month ago
3	Meagan Parrish Pharma Voice Senior editor @industrydive. Pharma world follower. Wisconsin, USA pharmaceuticalsjournalismparenting	Psychedelics haven’t fulfilled clinical expectations, but new trial strategies could turn the tide - about 1 month ago Despite adcomm rejection, Lykos CEO sees future for MDMA drug - 7 months ago
4	Oshan Jarow Vox Focus on consciousness, economics. Co-founder LE Possibility. Brooklyn, New York consciousnesseconomicspodcasting	The world’s most mysterious psychedelic is already inside your brain - about 2 months ago Nitrous, one of the oldest mind-altering drugs, is back - 4 months ago MDMA therapy didn’t get FDA approval. Now what? - 6 months ago Psychedelics are about to become a casualty of Oregon’s opioid crisis - 10 months ago Why psychedelics produce some of the most meaningful experiences in people’s lives - about 1 year ago Psychedelics can have enormous benefits, but the risks shouldn’t be ignored - about 1 year ago
5	Carly Cassella Science Alert Writer at ScienceAlert. Sciencewriting	First Traces of Ancient Egyptian Hallucinogens Found in Old Jug - about 2 months ago
6	Andrew Paul Popular Science Now on Bluesky America's Heartland Blueskywriting	Ancient Egyptian ritual potion included hallucinogens and bodily fluids - 2 months ago
7	Kristen Monaco MedPage Today	Psych Congress Roundup: Digital Tx for MDD; Esketamine Rooms; PA Contributions - 3 months ago More ADHD Drug Production; Psilocybin vs Lexapro; Addiction a Chronic Brain Disease? - 5 months ago FDA Rejects MDMA-Assisted Therapy for PTSD - 6 months ago MDMA for PTSD Under FDA Review; GLP-1 for Opioid Cravings; ADHD an Evolutionary Aid? - 11 months ago Psychedelics for Psych Conditions Made Their Mark in 2023 - about 1 year ago Another Mid-Stage Psychedelic Win; Gun Suicides Reach High; Magnetic Seizure Therapy - about 1 year ago
8	Marissa Plescia MedCity News Reporter at MedCity News. reportingjournalism	What’s Next for Psychedelic Medicines? - 3 months ago
9	Sophie Putka MedPage Today Enterprise, investigative writer. New York, USA enterprise journalisminvestigative journalism	A Miss for Steroid-Toting Red Blood Cells in Ataxia Telangiectasia - 5 months ago
10	Meghana Keshavan STAT News Biotech nerd and writer @statnews. biotechwriting	STAT+: Rick Doblin, ‘unleashed,’ blasts FDA over Lykos drug rejection and turns to global push for MDMA therapy - 5 months ago STAT+: Lykos Therapeutics cuts 75% of staff after FDA rejects MDMA-assisted therapy - 5 months ago A tough week for MDMA-assisted psychotherapy - 5 months ago STAT+: Three MDMA therapy papers retracted over data integrity concerns - 5 months ago FDA rejects MDMA as a psychedelic treatment for PTSD - 6 months ago Psychedelic investment continues to ramp up - 11 months ago

Journalists covering ecstasy